XIOR 27.650 € (-0,54 %) AB INBEV 67.620 € (-0,27 %) KBC 115.100 € (-0,52 %) BEKAERT 43.050 € (-0,81 %) AEDIFICA 71.950 € (-0,62 %) ARGENX SE 671.600 € (+0,06 %) COFINIMMO 84.600 € (+0,48 %) ACKERMANS V.HAAREN 289.800 € (-0,69 %) NEXTENSA 45.800 € (-2,66 %) ELIA GROUP 135.700 € (-0,95 %) UCB 234.400 € (+0,69 %) VGP 81.400 € (-6,22 %) ONWARD MEDICAL 2.790 € (+3,91 %) UMICORE 21.660 € (+2,75 %) TUBIZE-FIN 199.900 € (-0,15 %) MONTEA 70.800 € (+2,76 %) COLRUYT 32.280 € (+0,19 %) SOLVAY 26.680 € (-0,22 %) GIMV 48.550 € (-0,72 %) WDP 22.320 € (-0,45 %) VASTNED 28.550 € (-0,35 %) BARCO 9.025 € (+0,22 %) EVS BROADC.EQUIPM. 36.650 € (-1,87 %) OXURION 0.004 € (+5,26 %) TITAN S.A. 50.700 € (+1,64 %) SOFINA 219.800 € (-0,45 %) SYENSQO 57.050 € (-0,35 %) DECEUNINCK 2.065 € (+0,73 %) GBL 81.600 € (-0,37 %) ONTEX GROUP 2.805 € (-1,75 %) D'IETEREN GROUP 177.800 € (-1,00 %) AGEAS 67.250 € (-0,07 %) AZELIS GROUP 10.500 € (-0,10 %) MELEXIS 77.400 € (+0,52 %) SOLVAC NOM(RETAIL) 73.500 € (-2,65 %) PROXIMUS 6.630 € (+0,99 %) KBC ANCORA 79.500 € (-0,50 %) SHURGARD 26.000 € (-0,95 %) BPOST 1.704 € (+2,16 %) RECTICEL 10.400 € (+0,19 %) TESSENDERLO 21.050 € (-1,64 %) QUESTFOR GR-PRICAF 3.021 € (-0,97 %) TINC 12.000 € (-0,33 %) VAN DE VELDE 31.100 € (+0,32 %) KINEPOLIS GROUP 30.000 € (-0,66 %) ATENOR 1.760 € (+5,71 %) NYXOAH 2.765 € (+0,91 %) JENSEN-GROUP 70.400 € (+0,28 %) BREDERODE 102.400 € (-0,19 %) NYRSTAR 0.076 € (-5,26 %) FAGRON 24.350 € (-0,81 %) BELYSSE GROUP 0.586 € (-0,68 %) CENERGY 25.260 € (+2,43 %) DEME GROUP 198.000 € (-1,74 %) IBA 14.840 € (-0,40 %) EKOPAK 4.460 € (+0,22 %) CMB.TECH 12.760 € (+2,24 %) IMMOBEL 21.400 € (+1,42 %) RETAIL ESTATES 67.500 € (0,00 %) CARE PROPERTY INV. 13.140 € (+0,46 %)
STIF 50.300 € (+0,10 %)
CEGEDIM 10.800 € (-1,46 %)
ATON 0.015 € (+2,67 %)
EXOSENS 59.650 € (-2,85 %)
FDJ UNITED 22.510 € (-1,19 %)
LOUIS HACHETTE 1.580 € (-1,19 %)
SOITEC 164.800 € (+9,32 %)
THE NAVIGATOR COMP 3.270 € (-0,97 %)
VEOLIA ENVIRON. 35.780 € (-0,36 %)
ACCOR 44.390 € (-0,67 %)
L'OREAL 362.900 € (-1,12 %)
AIR LIQUIDE 175.480 € (-0,69 %)
PULLUP ENTERTAIN 9.000 € (+1,12 %)
LVMH 472.350 € (-1,24 %)
BNP PARIBAS ACT.A 91.520 € (-1,84 %)
SARTORIUS STED BIO 164.600 € (-0,18 %)
CAPGEMINI 104.000 € (-0,86 %)
COVIVIO 55.700 € (-0,18 %)
SOCIETE GENERALE 69.250 € (-0,55 %)
X-FAB 6.695 € (+0,60 %)
EURAZEO 48.200 € (-0,25 %)
MAGNUM 12.530 € (+1,02 %)
OVH 11.870 € (-0,75 %)
LEGRAND 157.050 € (-0,22 %)
ARCADIS 36.180 € (-1,95 %)
PROSUS 41.700 € (-0,62 %)
ASML HOLDING 1 303.200 € (+0,25 %)
AMUNDI 84.150 € (-0,53 %)
WENDEL 87.650 € (-0,40 %)
ORANGE 17.740 € (+0,40 %)
STMICROELECTRONICS 47.955 € (-0,62 %)
SCHNEIDER ELECTRIC 274.750 € (-0,16 %)
UNIBAIL-RODAMCO-WE 101.650 € (-0,49 %)
TELEPERFORMANCE 62.280 € (+0,94 %)
REXEL 37.960 € (+0,56 %)
ARKEMA 62.700 € (+0,64 %)
APERAM 48.680 € (+0,29 %)
BE SEMICONDUCTOR 254.100 € (-0,24 %)
RANDSTAD NV 25.550 € (-0,08 %)
ALTAREA 110.200 € (+0,55 %)
ALTEN 61.700 € (+0,08 %)
SAFRAN 291.200 € (-1,22 %)
GECINA 73.000 € (-1,15 %)
HEINEKEN HOLDING 60.800 € (-0,08 %)
AXA 41.210 € (-0,89 %)
HERMES INTL 1 670.000 € (-1,88 %)
SANOFI 73.030 € (-0,96 %)
KERING 246.750 € (-0,02 %)
DASSAULT SYSTEMES 19.925 € (+0,30 %)
RENAULT 28.540 € (-8,35 %)
VALEO 11.525 € (+0,39 %)
CARMILA 16.820 € (-1,06 %)
EXOR NV 69.200 € (+1,54 %)
DANONE 62.740 € (-0,85 %)
KLEPIERRE 34.400 € (+0,12 %)
AKZO NOBEL 50.920 € (-0,66 %)
ING GROEP N.V. 25.555 € (-0,76 %)
ALSTOM 17.355 € (-1,03 %)
VINCI 129.650 € (-1,44 %)
ESSILORLUXOTTICA 172.900 € (-1,93 %) News Réglementées
|
08/05/2026 11:00
Original-Research: OHB SE (von NuWays AG): BUYOriginal-Research: OHB SE - from NuWays AG Classification of NuWays AG to OHB SE
Scaling already before defence kicks in; PT Up OHB remains a compelling way to gain listed exposure to Europe’s sovereign space build-out. Q1 added another data point to the scaling story, while the larger defence ramp, potential equity funding and mix-driven margin upside are still ahead. The quarter showed continued progress, with total output up 15% yoy to € 279m and reported EBITDA up 48% yoy to € 25.7m, implying a 2pp yoy margin improvement to 9.2%. The run-rates support the FY guidance (output: +16% yoy, margin +1.8pp yoy). Meanwhile, order backlog reached a new record of € 3.4bn (+45% yoy). The implied order intake stood at c. € 439m, equivalent to a strong 1.6x book-to-bill. Importantly, neither order intake nor margins yet reflect the expected defence ramp or future mix shift towards higher-margin national defence and commercial opportunities. A potential capital increase should support the next leg of the investment case. Primary proceeds could fund OHB’s scale-up phase by increasing capacity to pre-finance and execute larger defence-space programmes, while a parallel KKR secondary would improve free float and institutional access from today’s very limited 5.7%. With the Fuchs family intending to remain clearly above 50%, the long-term entrepreneurial setup remains intact. With investor attention increasingly shifting towards space, supported by the potential SpaceX IPO and rising defence-space order momentum in Europe, OHB should benefit from a supportive news-flow backdrop. Strong sales growth into the next decade, further acceleration potential from national defence contracts and positive mix effects should drive margin expansion and a disproportionate EPS CAGR of 39% into 2030e (eNuW). Importantly, OHB’s right-to-win is rooted in decades of engineering know-how, customer trust and proven delivery capability. This should ensure that the company is not just exposed to the space theme, but one of its key European beneficiaries. Following the re-rating, OHB no longer screens as a classical near-term multiple discount story. Still, the valuation looks attractive relative to the duration and scarcity of the growth profile, in our view. OHB is the largest listed European space pure-play and one of only three leading space-systems providers for ESA. Moreover, compared to listed space peers, the stock still trades attractively at c. 4x EV/sales for 2026e vs. 5.2x median of the peer group, despite OHB’s unique track-record, profitability and institutional customer access. Action: We raise our terminal EBIT margin assumption to 13% from 11%, reflecting a structurally better mix from defence, secure space infrastructure and private commercial opportunities such as Moonport and Rocket Factory Augsburg. BUY, new PT € 320 (old: € 272), on DCF. You can download the research here: ohb-se-2026-05-08-previewreview-en-25842 For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2324012 08.05.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière